An antibody with Fab-constant domains exchanged for a pair of CH3 domains.

We have designed a complete antibody-like construct where the CH1 and Cκ domains are exchanged for a pair of the CH3 domains and efficient pairing of the heavy and light variable domain is achieved using "Knobs-into-Holes" strategy. This construct, composed of only naturally occurring immu...

Full description

Bibliographic Details
Main Authors: Gordana Wozniak-Knopp, Gerhard Stadlmayr, Jan Walther Perthold, Katharina Stadlbauer, Mathias Gotsmy, Stefan Becker, Florian Rüker
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5891013?pdf=render
id doaj-6fd29778184a4a0396484ba2c6136214
record_format Article
spelling doaj-6fd29778184a4a0396484ba2c61362142020-11-25T01:24:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01134e019544210.1371/journal.pone.0195442An antibody with Fab-constant domains exchanged for a pair of CH3 domains.Gordana Wozniak-KnoppGerhard StadlmayrJan Walther PertholdKatharina StadlbauerMathias GotsmyStefan BeckerFlorian RükerWe have designed a complete antibody-like construct where the CH1 and Cκ domains are exchanged for a pair of the CH3 domains and efficient pairing of the heavy and light variable domain is achieved using "Knobs-into-Holes" strategy. This construct, composed of only naturally occurring immunoglobulin sequences without artificial linkers, expressed at a high level in mammalian cells, however exhibited low solubility. Rational mutagenesis aimed at the amino acid residues located at the interface of the variable domains and the exchanged CH3 domains was applied to improve the biophysical properties of the molecule. The domain-exchanged construct, including variable domains of the HER2/neu specific antibody trastuzumab, was able to bind to the surface of the strongly HER2/neu positive cell line SK-BR3 4-fold weaker than trastuzumab, but could nevertheless incite a more potent response in an antibody-dependent cell cytotoxicity (ADCC) reporter assay with FcγRIIIa-overexpressing T-cells. This could be explained with a stronger binding to the FcγRIIIa. Importantly, the novel construct could mediate a specific ADCC effect with natural killer cells similar to the parental antibody.http://europepmc.org/articles/PMC5891013?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Gordana Wozniak-Knopp
Gerhard Stadlmayr
Jan Walther Perthold
Katharina Stadlbauer
Mathias Gotsmy
Stefan Becker
Florian Rüker
spellingShingle Gordana Wozniak-Knopp
Gerhard Stadlmayr
Jan Walther Perthold
Katharina Stadlbauer
Mathias Gotsmy
Stefan Becker
Florian Rüker
An antibody with Fab-constant domains exchanged for a pair of CH3 domains.
PLoS ONE
author_facet Gordana Wozniak-Knopp
Gerhard Stadlmayr
Jan Walther Perthold
Katharina Stadlbauer
Mathias Gotsmy
Stefan Becker
Florian Rüker
author_sort Gordana Wozniak-Knopp
title An antibody with Fab-constant domains exchanged for a pair of CH3 domains.
title_short An antibody with Fab-constant domains exchanged for a pair of CH3 domains.
title_full An antibody with Fab-constant domains exchanged for a pair of CH3 domains.
title_fullStr An antibody with Fab-constant domains exchanged for a pair of CH3 domains.
title_full_unstemmed An antibody with Fab-constant domains exchanged for a pair of CH3 domains.
title_sort antibody with fab-constant domains exchanged for a pair of ch3 domains.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description We have designed a complete antibody-like construct where the CH1 and Cκ domains are exchanged for a pair of the CH3 domains and efficient pairing of the heavy and light variable domain is achieved using "Knobs-into-Holes" strategy. This construct, composed of only naturally occurring immunoglobulin sequences without artificial linkers, expressed at a high level in mammalian cells, however exhibited low solubility. Rational mutagenesis aimed at the amino acid residues located at the interface of the variable domains and the exchanged CH3 domains was applied to improve the biophysical properties of the molecule. The domain-exchanged construct, including variable domains of the HER2/neu specific antibody trastuzumab, was able to bind to the surface of the strongly HER2/neu positive cell line SK-BR3 4-fold weaker than trastuzumab, but could nevertheless incite a more potent response in an antibody-dependent cell cytotoxicity (ADCC) reporter assay with FcγRIIIa-overexpressing T-cells. This could be explained with a stronger binding to the FcγRIIIa. Importantly, the novel construct could mediate a specific ADCC effect with natural killer cells similar to the parental antibody.
url http://europepmc.org/articles/PMC5891013?pdf=render
work_keys_str_mv AT gordanawozniakknopp anantibodywithfabconstantdomainsexchangedforapairofch3domains
AT gerhardstadlmayr anantibodywithfabconstantdomainsexchangedforapairofch3domains
AT janwaltherperthold anantibodywithfabconstantdomainsexchangedforapairofch3domains
AT katharinastadlbauer anantibodywithfabconstantdomainsexchangedforapairofch3domains
AT mathiasgotsmy anantibodywithfabconstantdomainsexchangedforapairofch3domains
AT stefanbecker anantibodywithfabconstantdomainsexchangedforapairofch3domains
AT florianruker anantibodywithfabconstantdomainsexchangedforapairofch3domains
AT gordanawozniakknopp antibodywithfabconstantdomainsexchangedforapairofch3domains
AT gerhardstadlmayr antibodywithfabconstantdomainsexchangedforapairofch3domains
AT janwaltherperthold antibodywithfabconstantdomainsexchangedforapairofch3domains
AT katharinastadlbauer antibodywithfabconstantdomainsexchangedforapairofch3domains
AT mathiasgotsmy antibodywithfabconstantdomainsexchangedforapairofch3domains
AT stefanbecker antibodywithfabconstantdomainsexchangedforapairofch3domains
AT florianruker antibodywithfabconstantdomainsexchangedforapairofch3domains
_version_ 1725118825734602752